Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Retained Earnings (2016 - 2025)

INVO Fertility (IVF) has disclosed Retained Earnings for 15 consecutive years, with -$93.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Retained Earnings fell 46.61% to -$93.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$93.1 million, a 46.61% decrease, with the full-year FY2024 number at -$67.2 million, down 16.17% from a year prior.
  • Retained Earnings was -$93.1 million for Q3 2025 at INVO Fertility, down from -$90.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$34.7 million in Q1 2021 to a low of -$93.1 million in Q3 2025.
  • A 5-year average of -$56.4 million and a median of -$54.6 million in 2023 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: dropped 13.37% in 2024, then crashed 46.61% in 2025.
  • INVO Fertility's Retained Earnings stood at -$38.9 million in 2021, then fell by 28.01% to -$49.8 million in 2022, then decreased by 16.14% to -$57.8 million in 2023, then fell by 16.17% to -$67.2 million in 2024, then plummeted by 38.61% to -$93.1 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Retained Earnings are -$93.1 million (Q3 2025), -$90.2 million (Q2 2025), and -$84.9 million (Q1 2025).